[go: up one dir, main page]

WO2004096765A3 - A novel crystalline polymorph of fluvastatin sodium and a process for preparing it - Google Patents

A novel crystalline polymorph of fluvastatin sodium and a process for preparing it Download PDF

Info

Publication number
WO2004096765A3
WO2004096765A3 PCT/IN2004/000121 IN2004000121W WO2004096765A3 WO 2004096765 A3 WO2004096765 A3 WO 2004096765A3 IN 2004000121 W IN2004000121 W IN 2004000121W WO 2004096765 A3 WO2004096765 A3 WO 2004096765A3
Authority
WO
WIPO (PCT)
Prior art keywords
fluvastatin sodium
preparing
novel crystalline
crystalline polymorph
antisolvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2004/000121
Other languages
French (fr)
Other versions
WO2004096765A2 (en
Inventor
Sanjay Suri
Gurdeep Singh Sarin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morepen Laboratories Ltd
Original Assignee
Morepen Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morepen Laboratories Ltd filed Critical Morepen Laboratories Ltd
Publication of WO2004096765A2 publication Critical patent/WO2004096765A2/en
Publication of WO2004096765A3 publication Critical patent/WO2004096765A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to a novel crystalline polymorphic form BA of Fluvastatin Sodium and hydrates thereof, characterized by its IR and PXRD analysis. The invention also provides a process for the preparation of the novel polymorph that involves use of aliphatic ethers as antisolvent to facilitate precipitating. Further the addition of antisolvent is preferably carried out at a temperature above 40°C in the absence of seeding.
PCT/IN2004/000121 2003-05-01 2004-04-30 A novel crystalline polymorph of fluvastatin sodium and a process for preparing it Ceased WO2004096765A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN656/DEL/2003 2003-05-01
IN656DE2003 2003-05-01

Publications (2)

Publication Number Publication Date
WO2004096765A2 WO2004096765A2 (en) 2004-11-11
WO2004096765A3 true WO2004096765A3 (en) 2005-01-27

Family

ID=33397659

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2004/000121 Ceased WO2004096765A2 (en) 2003-05-01 2004-04-30 A novel crystalline polymorph of fluvastatin sodium and a process for preparing it

Country Status (1)

Country Link
WO (1) WO2004096765A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432380B2 (en) 2003-10-16 2008-10-07 Ciba Specialty Chemicals Corp. Crystalline form of Fluvastatin sodium
WO2006030304A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof
JP2008515878A (en) * 2004-10-05 2008-05-15 バイオコン・リミテッド Method for producing amorphous fluvastatin sodium
US7795451B2 (en) 2005-02-11 2010-09-14 Jubilant Organosys Limited Polymorphic forms of fluvastatin sodium and process for preparing the same
WO2006109147A1 (en) * 2005-04-12 2006-10-19 Glenmark Pharmaceuticals Limited Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same
CA2642180A1 (en) * 2006-02-27 2007-09-07 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium novel forms and preparation therof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049681A1 (en) * 1996-06-24 1997-12-31 Astra Aktiebolag (Publ) Polymorphic compounds
WO2002036563A1 (en) * 2000-10-31 2002-05-10 Ciba Specialty Chemicals Holding Inc. Crystalline forms of fluvastatin sodium
WO2003013512A2 (en) * 2001-08-03 2003-02-20 Ciba Specialty Chemicals Holding Inc. Crystalline forms of fluvastatin sodium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997049681A1 (en) * 1996-06-24 1997-12-31 Astra Aktiebolag (Publ) Polymorphic compounds
WO2002036563A1 (en) * 2000-10-31 2002-05-10 Ciba Specialty Chemicals Holding Inc. Crystalline forms of fluvastatin sodium
WO2003013512A2 (en) * 2001-08-03 2003-02-20 Ciba Specialty Chemicals Holding Inc. Crystalline forms of fluvastatin sodium

Also Published As

Publication number Publication date
WO2004096765A2 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
AP1709A (en) Ethanolate of azithromycin, process for manufacure, and pharmaceutical compositions thereof.
TNSN06069A1 (en) Polymorphous forms of rifaximin as antibiotics
IL150227A0 (en) Processes for preparing clarithromycin polymorphs and novel polymorph iv
WO2003070725A3 (en) Process for preparing indolinone derivatives
WO2003059807A3 (en) Crystalline solids of carvedilol and processes for their preparation
EP2428519A3 (en) Process for the preparation of 17-vinyl- triflates as intermediates
WO2007103252A3 (en) Novel crystalline forms of antidiabetic compounds
EP1429757B8 (en) Crystalline forms of fluvastatin sodium
WO2006035277A3 (en) Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium
YU89402A (en) 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-/2,3'/ bipyridinyl in pure crystalline form and process for synthesis
WO2004096765A3 (en) A novel crystalline polymorph of fluvastatin sodium and a process for preparing it
KR20130014643A (en) Crystal form of quinoline compound and process for its production
WO2006095263A8 (en) Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
WO2008092939A3 (en) Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
WO2006041985A3 (en) Thienopyridinone compounds and methods of treatment
TW200616634A (en) Crystalline forms and process for preparing spiro-hydantoin compounds
SK50052004A3 (en) Novel form of N-(trans-4-isopropylcyclohexylcarbonyl)-D- phenylalanine
WO2009075516A3 (en) Process for preparing pantoprazole sodium sesquihydrate
IL141212A0 (en) Process for the synthesis of (1h)-benzo [c] quinolizin-3-one derivatives
EP1420028A3 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
WO2009021943A3 (en) Novel preparation process
NO20054911L (en) Process for preparing a polymorphous frosiglitazone maleate
WO2007031845A3 (en) Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
PL1948626T3 (en) Process for the preparation of delmopinol and derivatives thereof
MXPA05010165A (en) [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase